Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha
- PMID: 2108188
- DOI: 10.1016/0165-5728(90)90134-9
Transforming growth factors type beta 1 and beta 2 suppress rat astrocyte autoantigen presentation and antagonize hyperinduction of class II major histocompatibility complex antigen expression by interferon-gamma and tumor necrosis factor-alpha
Abstract
The transforming growth factors (TGF) type beta 1 and beta 2 are regulatory cytokines strongly affecting rat astrocyte immune functions. Both cytokines suppressed presentation of autoantigen by astrocytes: highly encephalitogenic T cells cocultured with TGF-beta-treated astrocytes in the presence of myelin basic protein did not become activated to transfer experimental allergic encephalomyelitis, a central nervous system (CNS) autoimmune disease. Furthermore, TGF-beta 1 and -beta 2 antagonized hyperinduction of astrocyte major histocompatibility complex (MHC) class II antigen expression by interferon-gamma and tumor necrosis factor-alpha. Thus, TGF-beta might be a potential regulator of CNS inflammation.
Similar articles
-
Astrocytes express elements of the class II endocytic pathway and process central nervous system autoantigen for presentation to encephalitogenic T cells.J Immunol. 1998 Dec 1;161(11):5959-66. J Immunol. 1998. PMID: 9834077
-
Ia-restricted encephalitogenic T lymphocytes mediating EAE lyse autoantigen-presenting astrocytes.Nature. 1986 Mar 6-12;320(6057):70-2. doi: 10.1038/320070a0. Nature. 1986. PMID: 2419764
-
Induction and regulation of class II major histocompatibility complex mRNA expression in astrocytes by interferon-gamma and tumor necrosis factor-alpha.J Neuroimmunol. 1990 Dec;30(2-3):189-200. doi: 10.1016/0165-5728(90)90103-t. J Neuroimmunol. 1990. PMID: 2121799 Free PMC article.
-
Astrocytes and intracerebral immune responses.J Clin Immunol. 1989 Jan;9(1):1-9. doi: 10.1007/BF00917121. J Clin Immunol. 1989. PMID: 2649507 Review.
-
Immune function of astrocytes.Glia. 2001 Nov;36(2):180-90. doi: 10.1002/glia.1107. Glia. 2001. PMID: 11596126 Review.
Cited by
-
Effects of transforming growth factor-beta on murine astrocyte glutamine synthetase activity. Implications in neuronal injury.J Clin Invest. 1992 Nov;90(5):1786-93. doi: 10.1172/JCI116053. J Clin Invest. 1992. PMID: 1358919 Free PMC article.
-
Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):421-5. doi: 10.1073/pnas.89.1.421. Proc Natl Acad Sci U S A. 1992. PMID: 1370356 Free PMC article.
-
Suppression of TGF-beta1 in human gliomas by retroviral gene transfection enhances susceptibility to LAK cells.J Neurooncol. 1999 May;43(1):27-34. doi: 10.1023/a:1006289901702. J Neurooncol. 1999. PMID: 10448868
-
Enhanced expression of transforming growth factor beta 1 in the rat brain after a localized cerebral injury.Brain Res. 1992 Aug 7;587(2):216-25. doi: 10.1016/0006-8993(92)91000-5. Brain Res. 1992. PMID: 1525658 Free PMC article.
-
Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids.Immunology. 1993 May;79(1):125-30. Immunology. 1993. PMID: 8509133 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials